Current Situation Analysis and Quality Evaluation of Chinese Clinical Practice Guidelines in General Practice
Background The clinical practice guidelines in general practice can improve healthcare quality in primary health care, however, no study has yet systematically investigated the current status and quality of the guidelines in China. Objective To investigate the current status and influencing factors of quality of the guidelines in China. Methods We searched China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform, Chinese biomedical literature database, and CQVIP website, and included the published guidelines in China. We analyzed the basic characteristics and used RIGHT to evaluate the reporting quality and AGREE-China for methodological quality. Results A total of 150 guidelines were included, mainly published from 2019 to 2021. Most of the guidelines〔108 (72.0%) 〕focused on the diagnosis and treatment of diseases. The top three specialties were cardiovascular disease〔40 (26.7%) 〕, gastroenterology〔31 (20.7%) 〕, and clinical pharmacy〔27 (18.0%) 〕. The main development institutions were the Chinese Medical Association and its branches〔123 (82.0%) 〕, the editorial committee of the Chinese Journal of General Practitioners〔119 (79.3%) 〕, and the Chinese Medical Journals Publishing House〔116 (77.3%) 〕. In terms of reporting quality, the average reporting rate of RIGHT was 23.6% (11.4%-42.9%) ; the reporting rate of basic information (59.8%) was higher, and that of evidence (0.3%) was the lowest. As for methodological quality, the average AGREE-China score was 23.4 (12.0-40.0) ; the reporting rates of conflicts of interest (63.0%) and availability/feasibility (53.0%) were higher, and that of economics (7.0%) was the lowest. Conclusion The number of Chinese clinical practice guidelines in general practice has increased rapidly in the past five years, which has played an important role in promoting the quality of primary health care. In the future, it is necessary to further develop the guidelines in different specialties and diseases and accelerate the methodology of development and reporting of the guidelines..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Zhongguo quanke yixue - 26(2023), 13, Seite 1551-1558 |
| Sprache: |
Chinesisch |
|---|
| Beteiligte Personen: |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Clinical practice guidelines|status analysis|quality evaluation|reporting guideline|general practice|primary health care|right|agree-china |
|---|
| doi: |
10.12114/j.issn.1007-9572.2023.0044 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ091493536 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ091493536 | ||
| 003 | DE-627 | ||
| 005 | 20240412093922.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240412s2023 xx |||||o 00| ||chi c | ||
| 024 | 7 | |a 10.12114/j.issn.1007-9572.2023.0044 |2 doi | |
| 035 | |a (DE-627)DOAJ091493536 | ||
| 035 | |a (DE-599)DOAJ60e73a54b57847e2ba8ee5a742c7996e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a chi | ||
| 100 | 0 | |a WANG Ping, WU Shouyuan, SUN Yajia, LAN Hui, REN Mengjuan, ZHAO Junxian, WANG Ling, SU Renfeng, ZHOU Qi, WANG Zijun, WANG Qi, MA Li, HOU Tianchun, CHEN Yaolong |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Current Situation Analysis and Quality Evaluation of Chinese Clinical Practice Guidelines in General Practice |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background The clinical practice guidelines in general practice can improve healthcare quality in primary health care, however, no study has yet systematically investigated the current status and quality of the guidelines in China. Objective To investigate the current status and influencing factors of quality of the guidelines in China. Methods We searched China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform, Chinese biomedical literature database, and CQVIP website, and included the published guidelines in China. We analyzed the basic characteristics and used RIGHT to evaluate the reporting quality and AGREE-China for methodological quality. Results A total of 150 guidelines were included, mainly published from 2019 to 2021. Most of the guidelines〔108 (72.0%) 〕focused on the diagnosis and treatment of diseases. The top three specialties were cardiovascular disease〔40 (26.7%) 〕, gastroenterology〔31 (20.7%) 〕, and clinical pharmacy〔27 (18.0%) 〕. The main development institutions were the Chinese Medical Association and its branches〔123 (82.0%) 〕, the editorial committee of the Chinese Journal of General Practitioners〔119 (79.3%) 〕, and the Chinese Medical Journals Publishing House〔116 (77.3%) 〕. In terms of reporting quality, the average reporting rate of RIGHT was 23.6% (11.4%-42.9%) ; the reporting rate of basic information (59.8%) was higher, and that of evidence (0.3%) was the lowest. As for methodological quality, the average AGREE-China score was 23.4 (12.0-40.0) ; the reporting rates of conflicts of interest (63.0%) and availability/feasibility (53.0%) were higher, and that of economics (7.0%) was the lowest. Conclusion The number of Chinese clinical practice guidelines in general practice has increased rapidly in the past five years, which has played an important role in promoting the quality of primary health care. In the future, it is necessary to further develop the guidelines in different specialties and diseases and accelerate the methodology of development and reporting of the guidelines. | ||
| 650 | 4 | |a clinical practice guidelines|status analysis|quality evaluation|reporting guideline|general practice|primary health care|right|agree-china | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 773 | 0 | 8 | |i In |t Zhongguo quanke yixue |d Chinese General Practice Publishing House Co., Ltd, 2024 |g 26(2023), 13, Seite 1551-1558 |w (DE-627)DOAJ090664779 |x 10079572 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2023 |g number:13 |g pages:1551-1558 |
| 856 | 4 | 0 | |u https://doi.org/10.12114/j.issn.1007-9572.2023.0044 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/60e73a54b57847e2ba8ee5a742c7996e |z kostenfrei |
| 856 | 4 | 0 | |u https://www.chinagp.net/fileup/1007-9572/PDF/zx20230044.pdf |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1007-9572 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2023 |e 13 |h 1551-1558 | ||